Korean Journal of Thoracic and Cardiovascular Surgery 2020; 53(2): 64-72  https://doi.org/10.5090/kjtcs.2020.53.2.64
Outcomes and Patency of Complex Configurations of Composite Grafts Using Bilateral Internal Thoracic Arteries
Beatrice Chia-Hui Shih , M.D.1, Suryeun Chung , M.D.2, Hakju Kim , M.D.1, Hyoung Woo Chang , M.D.1, Dong Jung Kim , M.D.1, Cheong Lim , M.D.1, Kay-Hyun Park , M.D.1, Jun Sung Kim , M.D.1
1Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam;
2Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Corresponding author: Jun Sung Kim
Tel 82-31-787-7139
Fax 82-31-787-4050
E-mail bboloc@snubh.org
Received: September 2, 2019; Revised: October 12, 2019; Accepted: October 28, 2019.; Published online: April 5, 2020.
© The Korean Journal of Thoracic and Cardiovascular Surgery. All rights reserved.

cc This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properlycited.


It is generally agreed that using a bilateral internal thoracic artery (BITA) composite graft improves long-term survival after coronary artery bypass grafting (CABG). Although the left internal thoracic artery (LITA)-based Y-composite graft is widely adopted, technical or anatomical difficulties necessitate complex configurations. We aimed to investigate whether BITA configuration impacts survival or patency in patients undergoing coronary revascularization.


Between January 2006 and June 2017, 1,161 patients underwent CABG at Seoul National University Bundang Hospital, where the standard technique is a LITA-based Y-composite graft with the right internal thoracic artery (RITA) sequentially anastomosed to non-left anterior descending (LAD) targets. Total of 160 patients underwent CABG using BITA with modifications. Their medical records and imaging data were reviewed retrospectively to investigate technical details, clinical outcomes, and graft patency.


Modifications of the typical Y-graft (group 1, n=90), LITA-based I-graft (group 2, n=39), and RITA-based composite graft (group 3, n=31) were used due to insufficient RITA length (47%), problems using LITA (28%), and target vessel anatomy (25%). The overall 30-day mortality rate was 1.9%. Among 116 patients who underwent computed tomography or conventional angiography at a mean interval of 29.9±33.1 months postoperatively, the graft patency rates were 98.7%, 95.3%, and 83.6% for the LAD, left circumflex artery, and right coronary artery territories, respectively. Patency rates for the inflow, secondary, and tertiary grafts were 98.2%, 90.5%, and 80.4%, respectively. The RITA-based graft (group 3) had the lowest patency rate of the various configurations (p<0.011).


LITA-based Y composite graft, showed satisfactory clinical outcomes and patency whereas modifications of RITA- based composite graft had the lowest patency and 5-year survival rates. Therefore, when using RITA-based composite graft, other options should be considered before proceeding atypical configurations.
Keywords: Coronary artery bypass, Composite graft, Bilateral internal thoracic artery, Coronary artery disease

The use of bilateral internal thoracic arteries (BITA) in coronary artery bypass grafting (CABG) is becoming increasingly popular, with accumulating evidence of improved graft patency and overall patient survival in left internal thoracic artery (LITA)-to-left anterior descending artery (LAD) anastomosis. However, the use of BITA is still relatively uncommon worldwide [1,2], possibly not only because the harvesting and utilization of BITA is time-consuming and technically complex, but also due to variations in coronary anatomy and the degree of coronary artery disease. Depending on the circumstances, anatomical or technical issues may necessitate modifications.

The current literature demonstrates no difference in clinical outcomes between composite and in situ graft configurations [3]; therefore, given the paucity of comparative data and information regarding the long-term outcomes of complex and atypical BITA configurations, we investigated the clinical outcomes of patients who received BITA grafts of various configurations at our institution. We assessed whether BITA configuration impacted survival or patency in patients undergoing CABG and whether any particular configuration was superior with respect to survival or the need for repeat revascularization.



Between January 2006 and June 2017, 1,161 consecutive patients underwent CABG with BITA composite grafting at Seoul National University Bundang Hospital. Of those, 160 patients required modifications of the graft configuration and were included in the present study. The composite BITA graft was modified for the following reasons: (1) 75 patients (47%) had a RITA with insufficient length for sequential anastomosis; (2) 45 patients (28%) had intrinsic LITA limitations due to left subclavian artery stenosis, ipsilateral arteriovenous fistula, or LITA injury during harvest; (3) 26 patients (16.3%) had non-triplet coronary disease; and (4) 14 patients (8.7%) exhibited target vessel size mismatch or an unsuitable geometric orientation for sequential anastomosis. From patients’ medical records, information was extracted on their demographics, preoperative risk factors, operative technique, postoperative hospital course, imaging data, and clinical outcomes. Data were reviewed retrospectively to investigate technical details, clinical outcomes, and graft patency.

The institutional review board of our institution approved the research design (IRB approval no., B-1909/565-107) and waived the need for informed consent.

Surgical technique

All patients underwent full median sternotomy. The standard technique at our institution was in situ LITA-based Y-composite grafting with the LITA anastomosed to the LAD and the right internal thoracic artery (RITA) sequentially anastomosed to non-LAD targets. The internal thoracic artery (ITA) was mostly harvested in a skeletonized fashion. More than half of the patients underwent off-pump CABG (59.4%), while the remainder underwent on-pump beating-heart or conventional CABG (40.6%) with antegrade cardioplegia due to a low ejection fraction or concomitant procedures.

We divided patients into 3 groups according to the types of modifications made. In group 1, the patients required minor alterations of the typical Y graft (Fig. 1A–D). In these patients, 4 different geometric or anastomotic configurations were identified: (Fig. 1A) a short RITA extended with a remaining segment of the LITA or an additionally-harvested saphenous vein graft, (Fig. 1B) a twisted Y configuration used due to size mismatch between the LITA and the LAD, (Fig. 1C) a secondary Y anastomosis made at the proximal or distal end of the RITA, and (Fig. 1D) a double Y or π configuration used for sequential anastomosis to non-LAD targets on the RITA.

In group 2, the RITA was anastomosed end-to-end to the LITA to create an I-composite graft (Fig. 1E, F) and was then anastomosed sequentially to the LAD or other territories. Finally, in group 3, the RITA was used as an inflow graft (Fig. 1G–J). This group also included 3 different geometric or anastomotic configurations: (Fig. 1G, H) a RITA-based I graft, (Fig. 1I) a RITA-based reverse T graft, and (Fig. 1J) a RITA-based Y graft.


All patients enrolled in the study participated in regular outpatient follow-up. The mean length of follow-up was 51.0±42.5 months (range, 3 days to 140 months). Graft patency was evaluated in a total of 116 patients (72.5%) using computed tomography (CT) coronary angiography (CAG) or conventional CAG with a mean interval of 29.9±31.1 months after CABG surgery. The imaging follow-up protocol at our institution was to perform CT angiography at 9 to 10 months postoperatively and to perform CAG at 5 years postoperatively. We defined graft failure as the total occlusion of the anastomosed graft as revealed on CT angiography during follow-up.

Statistical analysis

Preoperative demographic and investigative data, operative variables, 30-day mortality and morbidity, and 5-year survival were compared among the study groups. Categorical variables were expressed as number and percentage and were compared using the Fisher exact and Kruskal-Wallis tests. Continuous variables were expressed as mean±standard deviation and compared using the unpaired t-test. The Kaplan-Meier method was used to analyze overall survival and major adverse cardiovascular and cerebrovascular disease (MACCE)-free survival. Multivariate analyses were performed using logistic regression, and p-values <0.05 were considered to indicate statistical significance. We used IBM SPSS ver. 25.0 for Windows (IBM Corp., Armonk, NY, USA) for the statistical analysis.


Patient characteristics and early clinical outcomes

Among the 160 patients included in the study, 90 (56.3%), 39 (24.4%) and 31 (19.4%) patients were classified into groups 1, 2, and 3, respectively. The preoperative data are listed in Table 1. The mean age of the patients was 64.9± 10.7 years, and there were no significant demographic and clinical differences between the 3 groups apart from the incidence of chronic renal failure (CRF) and peripheral vascular disease. Group 3 had the highest rates of CRF (48.4%, p<0.001) and left main disease (83.9%). Group 2 had the highest rates of a preoperative history of myocardial infarction (28.2%), intra-aortic balloon pump insertion (12.8%), and peripheral vascular disease (31.6%).

Moreover, significant differences were observed in the operative characteristics of the 3 groups, as shown in Table 2. The number of anastomoses in total and in each coronary territory differed among groups. Group 1 had a clinically significantly greater number of anastomoses (3.8±0.9) than the other groups (2.6±1.0 in group 2 and 3.3±0.9 in group 3) (p<0.001). All 3 deaths (1.9%) that occurred within 30 days postoperatively were of noncardiac origin, and all occurred in group 2. In-hospital mortality was also highest in group 2 at 12.5% (p<0.011); among all patients, the cases of mortality included 2 cases of septic shock and 1 each of cardiac arrest, cardiogenic shock, and pulmonary hemorrhage. Early mortality and the occurrence of stroke differed significantly between groups (Table 3), with group 2 having the highest early mortality rate and group 3 having the highest rate of stroke.

Long-term survival

The overall 5-year survival rate was 82.6%, and the 5-year survival rates in groups 1, 2, and 3 were 86.7%, 80.1%, and 75.8%, respectively (p=0.076) (Fig. 2). There were no statistically significant differences in survival rate among groups. MACCEs were defined as all-cause mortality, stroke, myocardial infarction, and target vessel revascularization. The overall 5-year MACCE-free survival rate was 75.9% (p=0.006); group 1 had the highest survival rate to a significant extent at 84.2%, group 2 had a rate of 68.2%, and group 3 had the lowest rate at 65.7% (Fig. 3).

Graft patency

Graft failure was defined as total graft occlusion as shown on coronary CT angiography, according to the FitzGibbon grading system [4]. We further categorized graft patency by the anastomosed coronary territory and by the type of conduit. Table 4 demonstrates graft patency for each coronary territory. The total patency rates were 98.7%, 95.3%, and 83.6% for the LAD, left circumflex artery, and right coronary artery territories, respectively. Patency rates for the inflow graft, the secondary graft (anastomosed to the inflow graft), and the tertiary graft (anastomosed to the secondary graft) were 98.2%, 90.2%, and 80.4%, respectively at a mean interval of 29.9±31.1 months after CABG surgery (Tables 4, 5).


The current literature demonstrates the superiority of BITA over other types of conduits in patients undergoing CABG [5]. These benefits include increased short- and long-term patency, freedom from arteriosclerosis, and a higher survival rate in patients undergoing revascularization of the left coronary system [4,5]. Statistical adjustment has shown that graft configuration is not an independent predictor of repeat revascularization or mortality [5]. Additionally, previous studies have revealed that no single BITA graft configuration is superior to the others in terms of mortality or the need for repeat revascularization, apart from clear evidence supporting the use of the LITA-to-LAD graft. The use of the RITA as a second bypass conduit was a natural technical extension from these data. However, no consensus currently supports BITA grafting, as not all BITA configurations are equally effective. Our study therefore aimed to investigate whether any particular configuration was advantageous in terms of clinical outcomes and to attempt to determine the influence of configuration on graft patency.

Group 1 consisted of patients who underwent a typical LITA in situ Y-composite graft using RITA with additional conduits. In the case of LITA-based in situ conduits, geometric factors such as graft tension or torsion may mitigate any advantage gained by using the RITA as a composite graft. However, the use of composite grafting does allow the left-sided vessels to be bypassed with the BITA, without requiring proximal anastomosis to the aorta, and provides less concern regarding vessel length. A Y-composite graft was constructed when the RITA was too short to reach the left coronary artery territory or when the left coronary artery territory could not be completely revascularized with bilateral in situ ITA grafts. Nonetheless, the modified Y-composite graft allowed for more anastomoses than the single in situ LITA graft. This explains why group 1 had the highest survival and patency rates; the total number of anastomoses was greater, yielding higher revascularization of the left coronary circulation (Table 2). Our adaptation of RITA as a composite graft to bypass either the right or the left coronary circulation after LITA-to-LAD anastomosis was in congruency with 2 previous large series [6,7], and our results showed that this is likely the most effective bypass configuration.

Group 2 patients—those who underwent surgery using the LITA-based I-shaped RITA configuration—had the poorest clinical outcomes, with the highest 30-day mortality and in-hospital mortality rates. As mentioned earlier, this could have been due to underlying preoperative conditions unfavorable to revascularization as well as to vascular compromise. Whether the I-configuration itself was the paramount contributor to these poor outcomes is still undetermined. According to a previous mechanical study by Fan et al. [8], which assessed the difference in intramural stresses between end-to-side and end-to-end anastomoses, the proliferative influence of increased compliance mismatch on suture-line intimal hyperplasia was greater in end-to-side than in end-to-end anastomoses. In the present study, the configuration used in group 2 was an I-shaped end-to-end anastomosis, first anastomosed to the left coronary circulation and then extending to the right coronary circulation. Intramural stress alone therefore cannot be the factor that induced intimal hyperplasia compromising vascular integrity; instead, the anastomosis to the distal branches of the RCA with the free RITA in a composite configuration may have resulted in flow competition or limited flow to secondary and tertiary sites. The longer the arterial configuration, the lower the pressure at the distal anastomosis [9], and lower pressure in the distal portion of the Y branch may have compromised the distal anastomosis as well. However, the in-hospital and 30-day mortality rates in this group did not result from revascularization. The mortality cases were mostly of noncardiac origin, meaning that the high mortality rates in group 2 can be attributed to that group’s preoperative risk factors and vascular compromise due to underlying medical conditions, rather than to the graft configuration. Preoperative intra-aortic balloon pump insertion, atrial fibrillation, and peripheral vascular disease likely led to vascular compromise and low cardiac function, which resulted in subsequent in-hospital mortality from causes such as cardiogenic shock and cardiac arrest [10]. Nevertheless, this configuration may be assumed in selected patients, since the high mortality rate notwithstanding, overall 5-year survival and MACCE-free survival were higher than in group 3 (Fig. 3).

Lastly, the configuration used in group 3 was a RITA-based composite graft. In this group, the RITA was generally anastomosed to the left coronary circulation first, and the distal end of the LITA was anastomosed to the distal branch of the RCA. As in group 2, anastomosing the distal branch with the free RITA in a composite configuration is associated with a risk of flow competition [8], and due to the lower pressure in the distal portion of the I branch, competitive flow was more frequent at the right coronary bed than at the left. In addition, in accordance with a previous study by Glindeur et al. [11], our study showed that grafting of the intermediate branch or of the distal RCA negatively impacted the prognosis of graft function and thus patency. Group 3 had lower 30-day mortality and in-hospital mortality rates than group 2. However, the patency, overall 5-year survival, and MACCE-free survival rates were lowest in group 3, which could be attributed to ineffective revascularization. The configuration used in this group may cause kinking of the intermediate anastomoses, especially if the proximal Y anastomoses were performed near the pulmonary artery, were inside the pericardium, or were compressed by the myocardium [11,12]. Such secondary and tertiary sites had the lowest patency rates.

Although previous studies have shown no difference in long-term survival or freedom from repeat revascularization between different BITA configurations [12-20], and although those studies have also shown that no particular configuration is associated with relatively favorable clinical outcomes, our study revealed that certain aspects of the configuration must be considered. The selection of the ideal BITA configuration should be based on technical factors associated with the individual patient. The RITA-based composite graft showed the lowest patency rates in the distal RCA territory; thus, in patients in need of revascularization of the right coronary system, this configuration must be discouraged. In contrast, when possible, a LITA-based Y-composite graft should be performed, with the LITA-to-LAD graft serving as the gold standard (as in previous studies) because it is expected to yield successful revascularization and thus better clinical outcomes. In general, the technically simplest technique should be selected, as more complex configurations offer no additional benefit to patients. Further studies assessing the mechanical dynamics of graft configurations are necessary to provide clearer insight into relatively favorable configurations.

This study was limited by its retrospective nature. Graft patency could be evaluated shortly after surgery in only about 70% of patients, with most evaluations performed within 6 months to 2 years postoperatively. The long-term patency rate could not be uniformly assessed, and the method of patency evaluation was also inconsistent. Postoperative CT angiography and CAG were not previously designated in the postoperative patient groups, and the possibility of the imaging modality either overestimating or underestimating graft patency cannot be excluded. We also could not enroll all patients in imaging follow-up during a specific postoperative period, which may have affected the analysis of patency. Unquantifiable factors such as underlying comorbidities, the target vessel, and conduit quality could not be accounted for by risk adjustment. Additionally, this study did not investigate important clinical endpoints, such as recurrent myocardial infarction and repeat revascularization, which could reflect graft patency.

In conclusion, recent studies have shown that there is no difference in clinical outcomes between composite graft and in situ graft configurations and that BITA configuration does not affect mortality, graft patency, or the need for repeat revascularization. However, our study found that although atypical configurations were associated with relatively acceptable clinical outcomes and patency rates, the LITA-based Y-composite graft continues to be the gold standard graft configuration. Although the BITA composite configuration can be modified in response to unexpected intraoperative technical difficulties or limitations such as a short length or complex sequential anastomosis, a RITA-based composite graft should not be the first resort in patients in need of right coronary revascularization along with LAD revascularization. However, this does not mean that such a configuration must always be discouraged, because existing studies still advocate that no particular graft configuration is better than another, apart from LITA-to-LAD anastomoses. Patients requiring multivessel coronary surgery should be strongly considered for BITA grafting and revascularization, even with atypical configurations, when clinical factors permit.

Conflict of interest

No potential conflict of interest relevant to this article was reported.


This work was supported by Grant (Grant no., 02-2013-062) from the SNUBH research fund. Research associate Hyun Jeong Han (RN) helped us collect and manage the data.

Fig. 1. Methods of modifications. Group 1: modification of a typical Y graft (n=90, 56.3%). (A) The short right internal thoracic artery was extended with the remaining LITA or an additional saphenous vein graft (n=65). (B) Twisted Y graft for LITA-left anterior descending artery mismatch (n=12). (C) Secondary Y graft (n=9). (D) Double Y or π graft (n=4). Group 2: LITA-based I composite graft (n=39, 24.4%). (E) LITA-based I graft to the LAD (n=32). (F) LITA-based I graft to an area other than the LAD (n=7). Group 3: RITA-based composite graft (n=31, 19.4%). (G, H) RITA-based I graft (n=25). (I) RITA-based reverse T or U graft (n=3). (J) RITA-based Y graft (n=3). LITA, left internal thoracic artery; LAD, left anterior descending artery; RITA, right internal thoracic artery.
Fig. 2. Overall survival. (A) All patients. (B) By group. LITA, left internal thoracic artery; RITA, right internal thoracic artery.
Fig. 3. MACCE-free survival. (A) All patients. (B) By group. MACCE, major adverse cardiovascular and cerebrovascular event; LITA, left internal thoracic artery; RITA, right internal thoracic artery.

Preoperative characteristics of patients

Characteristic Total Group 1: modification of Y graft Group 2: LITA-based I graft Group 3: RITA-based graft p-value
No. of patients 160 90 39 31
Age (yr) 64.9±10.7 64.3±11.1 65.5±11.0 65.9±9.1 0.924
Sex (male) 114 (71.3) 64 (71.1) 28 (71.8) 22 (71.0) 0.996
Smoker 83 (51.9) 46 (51.1) 24 (61.5) 13 (41.9) 0.258
Hypertension 122 (76.3) 70 (77.8) 30 (76.9) 22 (71.0) 0.740
Diabetes mellitus 98 (61.3) 57 (63.3) 20 (51.3) 21 (67.7) 0.309
Dyslipidemia 60 (37.5) 38 (42.2) 13 (33.3) 9 (29.0) 0.351
Chronic renal failure 29 (18.1) 9 (10.0) 5 (12.8) 15 (48.4) <0.001
Prior myocardial infarction
Acute 43 (26.9) 27 (30.0) 10 (25.6) 6 (19.4) 0.504
Old 38 (23.8) 23 (25.6) 11 (28.2) 4 (12.9) 0.272
Coronary disease
1-Vessel disease 1 (0.63) 1 (1.11) 0 0
2-Vessel disease 32 (20.3) 10 (11.1) 17 (43.6) 5 (16.1)
3-Vessel disease 125 (79.1) 79 (87.8) 22 (56.4) 26 (83.9)
Left main disease 35 (22.2) 16 (17.8) 7 (17.9) 12 (30.7)
Prior stroke 44 (27.5) 21 (23.3) 12 (30.8) 11 (35.5) 0.371
Chronic obstructive pulmonary disease 14 (8.8) 10 (11.1) 2 (5.4) 2 (6.5) 0.513
Atrial fibrillation 11 (6.9) 5 (5.6) 5 (12.8) 1 (3.2) 0.218
Peripheral vascular disease 29 (18.1) 10 (11.4) 12 (31.6) 7 (22.6) 0.022
Left ventricular ejection fraction ≤40% 42 (26.3) 27 (30.0) 9 (24.3) 6 (19.4) 0.481
Preoperative intra-aortic balloon pump 16 (10.0) 8 (8.9) 5 (12.8) 3 (9.7) 0.790

Values are presented as number, mean±standard deviation, or number (%).

LITA, left internal thoracic artery; RITA, right internal thoracic artery.

Operative data

Variable Total Group 1: modification of Y graft Group 2: LITA-based I graft Grouup 3: RITA-based graft p-value
No. of patients 160 90 39 31
Surgical acuity
Urgent 38 (23.8) 23 (25.6) 7 (17.9) 8 (25.8) 0.619
Emergent 9 (5.6) 4 (4.4) 3 (7.7) 2 (6.5) 0.647
No. of anastomosis
Total 3.4±1.1 3.8±0.9 2.6±1.0 3.3±0.9 <0.001
Left anterior descending artery 1.0±0.2 1.0±0.1 0.9±0.3 0.9±0.2 0.040
Laterala) 1.4±0.9 1.7±0.8 0.7±0.8 1.3±0.7 <0.001
Right coronary arteryb) 1.1±0.5 1.1±0.5 1.0±0.5 1.1±0.6 0.597
Isolated CABG 135 (84.4) 82 (91.1) 29 (74.4) 24 (77.4) 0.024
Cardiopulmonary bypass status
Off-pump CABG 95 (59.4) 52 (57.8) 21 (53.8) 22 (71.0) 0.314
On-pump beating CABG 65 (40.6) 38 (42.2) 18 (46.2) 9 (29.0) 0.314
Conventional CABG 33 (20.6) 13 (14.4) 13 (33.3) 7 (22.6) 0.049

Values are presented as number, number (%) or mean±standard deviation.

LITA, left internal thoracic artery; RITA, right internal thoracic artery; CABG, coronary artery bypass grafting.

a)Diagonal/Ramus/obtuse marginal artery. b)Posterolateral branch/posterior descending artery.

Early clinical outcomes

Variable Total Group 1: modification of Y graft Group 2: LITA-based I graft Group 3: RITA-based graft p-value
No of patients 160 90 39 31
30-day mortalitya) 3 (1.9) 0 3 (7.7) 0 0.020
In-hospital mortalityb) 8 (5.0) 1 (1.1) 5 (12.8) 2 (6.5) 0.011
Hospital stay (day) 12.6±15.5 12.4±16.0 10.3±6.7 16.1±21.1 0.178
Reoperation for bleeding 3 (1.9) 2 (2.2) 1 (2.6) 0 1.000
Stroke 4 (2.5) 0 1 (2.6) 3 (9.7) 0.011
Acute renal failure requiring dialysis 2 (1.3) 0 2 (5.1) 0 0.095
Respiratory complication 6 (3.8) 1 (1.1) 3 (7.7) 2 (6.5) 0.079
Arrhythmia 5 (3.1) 3 (3.3) 2 (5.1) 0 0.593
Wound complication
Superficial wound infection 5 (5.0) 4 (4.4) 2 (5.1) 2 (6.5) 0.887
Mediastinitis 4 (2.5) 2 (2.2) 0 2 (6.5) 0.214

Values are presented as number, number (%) or mean±standard deviation.

LITA, left internal thoracic artery; RITA, right internal thoracic artery.

a)Acute respiratory distress syndrome (n=1), cerebral infarction (n=1), and bowel infarction (n=1). b)Conditions listed above (n=3), septic shock (n=2), cardiac arrest (n=1), cardiogenic shock (n=1), and pulmonary hemorrhage (n=1).

Graft patency by coronary territory

Territory Total (n=116) Modification of Y graft (n=67) LITA-based I graft (n=29) RITA-based graft (n=20)
LAD (LAD/D) 98.7 (152/154) 100.0 (96/96) 100.0 (33/33) 92.0 (23/25)
LCX (RI/OM/dLCX) 95.3 (121/127) 98.9 (91/92) 69.2 (9/13) 95.5 (21/22)
RCA (PDA/PLb) 83.6 (97/116) 88.2 (60/68) 79.3 (23/29) 73.7 (14/19)

Values are presented as % (number).

LITA, left internal thoracic artery; RITA, right internal thoracic artery; LAD, left anterior descending artery; D, diagonal; LCX, left circumflex artery; RI, ramus intermedius artery; OM, obtuse marginal artery; dLCX, distal left circumflex artery; RCA, right coronary artery; PDA, posterior descending artery; PLb, posterolateral branch.

Graft patency by type of conduit

Conduit Total (n=116) Modification of Y graft (n=67) LITA-based I graft (n=29) RITA-based graft (n=20)
Inflow graft 98.2 (114/116) 98.5 (66/67) 100 (29/29) 95 (19/20)
Secondary graft 90.2 (105/116) 95.5 (64/67) 89.7 (26/29) 75 (15/20)
Total occlusion 8 2 3 3
Distal occlusion 3 1 0 2
Tertiary graft 80.4 (66/82) 83.6 (51/61) 70 (7/10) 72.7 (8/11)

Values are presented as % (number) or number.

LITA, left internal thoracic artery; RITA, right internal thoracic artery.

  1. Tabata M, Grab JD, Khalpey Z, et al. Prevalence and variability of internal mammary artery graft use in contemporary multivessel coronary artery bypass graft surgery: analysis of the Society of Thoracic Surgeons National Cardiac Database. Circulation 2009;120:935-40.
    Pubmed CrossRef
  2. Kappetein AP, Dawkins KD, Mohr FW, et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease: insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg 2006;29:486-91.
    Pubmed CrossRef
  3. Kelleher R, Gimpel D, McCormack DJ, El-Gamel A. Does the use of an in situ or Y-configuration for bilateral internal thoracic arteries influence long-term survival, patency or repeat revascularization in coronary bypass surgery?. Interact Cardiovasc Thorac Surg 2019;28:222-6.
    Pubmed CrossRef
  4. FitzGibbon GM, Burton JR, Leach AJ. Coronary bypass graft fate: angiographic grading of 1400 consecutive grafts early after operation and of 1132 after one year. Circulation 1978;57:1070-74.
    Pubmed CrossRef
  5. Taggart DP, D'Amico R, Altman DG. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 2001;358:870-5.
    Pubmed CrossRef
  6. Sabik JF 3rd, Stockins A, Nowicki ER, et al. Does location of the second internal thoracic artery graft influence outcome of coronary artery bypass grafting?. Circulation 2008;118:S210-5.
    Pubmed CrossRef
  7. Toker ME, Omeroglu SN, Kirali K, Balkanay M, Yakut C. Using the bilateral internal mammary artery in the left or right coronary artery system: 5-year comparison of operation techniques and angiographic results. Heart Surg Forum 2005;8:E462-7.
    Pubmed CrossRef
  8. Fan T, Lu Y, Gao Y, et al. Hemodynamics of left internal mammary artery bypass graft: effect of anastomotic geometry, coronary artery stenosis, and postoperative time. J Biomech 2016;49:645-52.
    Pubmed CrossRef
  9. Glineur D, Kuschner CE, Grau JB. Bilateral internal thoracic artery graft configuration and coronary artery bypass grafting conduits. Curr Opin Cardiol 2016;31:625-34.
    Pubmed CrossRef
  10. Hori D, Yamaguchi A, Adachi H. Coronary artery bypass surgery in end-stage renal disease patients. Ann Vasc Dis 2017;10:79-87.
    Pubmed KoreaMed CrossRef
  11. Glineur D, Hanet C, D'hoore W, et al. Causes of non-functioning right internal mammary used in a Y-graft configuration: insight from a 6-month systematic angiographic trial. Eur J Cardiothorac Surg 2009;36:129-36.
    Pubmed CrossRef
  12. Magruder JT, Young A, Grimm JC, et al. Bilateral internal thoracic artery grafting: does graft configuration affect outcome?. J Thorac Cardiovasc Surg 2016;152:120-7.
    Pubmed CrossRef
  13. Gaudino M, Taggart D, Suma H, Puskas JD, Crea F, Massetti M. The choice of conduits in coronary artery bypass surgery. J Am Coll Cardiol 2015;66:1729-37.
    Pubmed CrossRef
  14. Dar MI, Dar AH, Bilal M, Ahmad M, Haseeb A. Association of internal mammary artery flow with different comorbidities and postcoronary artery bypass graft complications. Cureus 2017;9:.
    Pubmed KoreaMed CrossRef
  15. Gansera B, Gunzinger R, Angelis , et al. End of the millennium: end of the single thoracic artery graft?: two thoracic arteries: standard for the next millenium?.: early clinical results and analysis of risk factors in 1,487 patients with bilateral internal thoracic artery grafts. Thorac Cardiovasc Surg 2001;49:10-5.
    Pubmed CrossRef
  16. Gatti G, Castaldi G, Morosin M, et al. Double versus single source left-sided coronary revascularization using bilateral internal thoracic artery graft alone. Heart Vessels 2018;33:113-25.
    Pubmed CrossRef
  17. Di Mauro M, Iaco AL, Allam A, et al. Bilateral internal mammary artery grafting: in situ versus Y-graft: similar 20-year outcome. Eur J Cardiothorac Surg 2016;50:729-34.
    Pubmed CrossRef
  18. Lev-Ran O, Matsa M, Ishay Y, Shabtai A, Vodonos A, Sahar G. Retroaortic right internal thoracic artery grafting of circumflex artery targets. Asian Cardiovasc Thorac Ann 2015;23:543-51.
    Pubmed CrossRef
  19. Bakay C, Onan B, Korkmaz AA, Onan IS, Ozkara A. Sequential in situ left internal thoracic artery grafting to the circumflex and right coronary artery areas. Ann Thorac Surg 2013;95:63-70.
    Pubmed CrossRef
  20. Raja SG, Benedetto U, Husain M, et al. Does grafting of the left anterior descending artery with the in situ right internal thoracic artery have an impact on late outcomes in the context of bilateral internal thoracic artery usage?. J Thorac Cardiovasc Surg 2014;148:1275-81.
    Pubmed CrossRef

This Article